Login / Signup

[Application of HS221GI in treatment of influenza and ARVI in adults: a new approach - managing virus-induced inflammation. Results of a double-blind, randomized, placebo-controlled, multicenter clinical trial].

A G MalyavinM I BagaevaO V Kalyuzhin
Published in: Terapevticheskii arkhiv (2023)
is an effective and safe treatment for influenza and other ARVI in adults.
Keyphrases
  • double blind
  • placebo controlled
  • clinical trial
  • open label
  • phase ii
  • phase iii
  • study protocol
  • randomized controlled trial
  • combination therapy
  • high glucose